UK firm links with up global drug firms to make synthetic antibodies capable of binding to targets such as tumour cells Inside a science park lab next to the University of York, two clusters of robots are busy moving clear plates with mechanical arms as they screen many millions of molecules. The machines need only 24 hours to complete work that would usually take teams of human scientists several days. The lab is run by Aptamer Group, a small biotech firm that has quietly carved out a leading p...
UK firm links with up global drug firms to make synthetic antibodies capable of binding to targets such as tumour cells Inside a science park lab next to the University of York, two clusters of robots are busy moving clear plates with mechanical arms as they screen many millions of molecules. The machines need only 24 hours to complete work that would usually take teams of human scientists several days. The lab is run by Aptamer Group, a small biotech firm that has quietly carved out a leading p...
Share this Article
Recommended